Market Value9,760,868,193
Total Holdings71
File Date2026-02-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ELYM / Eliem Therapeutics, Inc.
WVE / Wave Life Sciences Ltd.
ACLX / Arcellx, Inc.
EWTX / Edgewise Therapeutics, Inc.
SRZN / Surrozen, Inc.
CDTX / Cidara Therapeutics, Inc.
TSHA / Taysha Gene Therapies, Inc.
VOR / Vor Biopharma Inc.
IRON / Disc Medicine, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
BLTE / Belite Bio, Inc - Depositary Receipt (Common Stock)
HCAT / Health Catalyst, Inc.
IVVD / Invivyd, Inc.
KIDS / OrthoPediatrics Corp.
LBRX / LB Pharmaceuticals Inc
MDLN / Medline Inc.
MNPR / Monopar Therapeutics Inc.
PGNY / Progyny, Inc.
PRAX / Praxis Precision Medicines, Inc.
QGEN / Qiagen N.V.
SABS / SAB Biotherapeutics, Inc.
BNTC / Benitec Biopharma Inc.
EVMN / Evommune, Inc.
JBIO / Jade Biosciences, Inc.
NUVL / Nuvalent, Inc.
GHRS / GH Research PLC
PALI / Palisade Bio, Inc.
ACET / Adicet Bio, Inc.
WAY / Waystar Holding Corp.
ASND / Ascendis Pharma A/S
SEPN / Septerna, Inc.
SYRE / Spyre Therapeutics, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
BCAX / Bicara Therapeutics Inc.
JANX / Janux Therapeutics, Inc.
HOWL / Werewolf Therapeutics, Inc.
NAMS.W / NewAmsterdam Pharma Company N.V. - Equity Warrant
OLMA / Olema Pharmaceuticals, Inc.
PEPG / PepGen Inc.
FDMT / 4D Molecular Therapeutics, Inc.
AVTX / Avalo Therapeutics, Inc.
LRMR / Larimar Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
SRRK / Scholar Rock Holding Corporation
PRME / Prime Medicine, Inc.
CTMX / CytomX Therapeutics, Inc.
EXAS / Exact Sciences Corporation
ETNB / 89bio, Inc.
EVH / Evolent Health, Inc.
MTSR / Metsera, Inc.
TNGX / Tango Therapeutics, Inc.
RCUS / Arcus Biosciences, Inc.
GKOS / Glaukos Corporation
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
ACET / Adicet Bio, Inc.
ELDN / Eledon Pharmaceuticals, Inc.
ASMB / Assembly Biosciences, Inc.
DNTH / Dianthus Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
FULC / Fulcrum Therapeutics, Inc.
IFRX / InflaRx N.V.
RZLT / Rezolute, Inc.
QURE / uniQure N.V.
LENZ / LENZ Therapeutics, Inc.
CTNM / Contineum Therapeutics, Inc.
HNGE / Hinge Health, Inc.
WGS / GeneDx Holdings Corp.
DSGN / Design Therapeutics, Inc.
OVID / Ovid Therapeutics Inc.
LXEO / Lexeo Therapeutics, Inc.
ARTV / Artiva Biotherapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
INSP / Inspire Medical Systems, Inc.
ACRV / Acrivon Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
SION / Sionna Therapeutics, Inc.
GRAL / GRAIL, Inc.
PTN / Palatin Technologies, Inc.
PCSC / Perceptive Capital Solutions Corp
SPRY / ARS Pharmaceuticals, Inc.
SLDB / Solid Biosciences Inc.
RNA / Atrium Therapeutics, Inc.
RANI / Rani Therapeutics Holdings, Inc.
TYRA / Tyra Biosciences, Inc.
GERN / Geron Corporation
CCCC / C4 Therapeutics, Inc.
NKTX / Nkarta, Inc.
CAPR / Capricor Therapeutics, Inc.
MLYS / Mineralys Therapeutics, Inc.